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Bisphenol A [BPA; 2,2-bis(4-hydroxy-
phenyl)propane] has a symmetrical chemical
structure of HO-C6H4-C(CH3)2-C6H4-OH.
BPA is used mainly in the production of poly-
carbonate plastics and epoxy resins. Its world-
wide manufacture is approximately 3.2 million
metric tons/year. BPA has been acknowledged
to be an estrogenic chemical able to interact
with human estrogen receptors (ER) (Dodds
and Lawson 1938; Krishnan et al. 1993; Olea
et al. 1996), and many lines of evidence have
revealed that BPA, at even low doses, acts as an
endocrine disruptor (Gupta 2000; Nagel et al.
1997; vom Saal et al. 1998; Welshons et al.
2003). However, its binding to and hormonal
interaction with ER are extremely weak,
2–3 orders of magnitude lower than those of
natural hormones, and thus the intrinsic signiﬁ-
cance of these low-dose effects is rather intangi-
ble and obscure (Safe et al. 2002). These facts
led us to hypothesize that BPA may interact
with nuclear receptors (NRs) other than ER.
We have recently demonstrated that BPA
binds strongly to estrogen-related receptor-γ
(ERR-γ) with high constitutive activity
(Takayanagi et al. 2006). ERR-γ is a member
of the human NR family and the estrogen-
related receptor (ERR) subfamily of orphan
NRs, which are closely related to the ERs
ER-α and ER-β (Giguère 2002; Horard and
Vanacker 2003). The ERR family includes
three members—ERR-α, ERR-β, and
ERR-γ—with ERR-γ being the most recently
identified (Eudy et al. 1998; Hong et al.
1999). The amino acid sequences are quite
highly conserved among ERRs and ERs, but
17β-estradiol (E2), a natural ligand of ERs,
does not bind to any of the ERR family
members. Our discovery that BPA binds
strongly to ERR-γ, but not to ERs, indicates
that the effects of the so-called endocrine dis-
ruptors should be examined for all NRs
without delay.
ERR-γ is expressed in a tissue-restricted
manner—for example, very strongly in the
mammalian brain during development, and
then in the brain, lung, and many other tissues
during adulthood (Eudy et al. 1998; Heard
et al. 2000; Lorke et al. 2000). Our preliminary
results have shown that the highest expression
is brought about in the placenta (Takeda Y,
Sumiyoshi M, Liu X, Matsushima A,
Shimohigashi M, Shimohigashi Y, unpub-
lished data). Strong binding of BPA to
ERR-γ would affect not only the physiologic
functions but also the metabolism of this NR
as a transcription-activating factor. Although
the intrinsic physiologic functions of ERR-γ
have not yet been clariﬁed, it is crucial that a
structure–function study be performed to
clarify the structural requirements for the
binding of BPA to ERR-γ.
In a previous study (Takayanagi et al.
2006), we used tritium (3H)-labeled
4-hydroxytamoxifen (4-OHT) as a tracer in a
receptor binding assay for ERR-γ. 4-OHT
binds strongly to ERR-γ and deactivates it as
an inverse agonist, decreasing the very high
level of spontaneous constitutive activity
(Coward et al. 2001). As a substitute for
[3H]4-OHT, BPA was found to be as potent
as 4-OHT in this binding assay. Furthermore,
BPA was found to retain or rescue ERR-γ’s
high basal constitutive activity in the reporter
gene assay for ERR-γ using HeLa cells. These
results indicated that BPA and 4-OHT bind
to ERR-γ with equal strength, but have struc-
tural differences that affect their occupation
of ERR-γ’s ligand binding pocket. In the
complex formed between 4-OHT and the
ERR-γ–ligand binding domain (LBD),
4-OHT remained at the ligand binding pocket
of ERR-γ–LBD, but the α-helix 12 of the
receptor was repositioned from the activation
conformation (Greschik et al. 2004; Wang
et al. 2006). In contrast, BPA was suggested to
bind to the pocket without changing the posi-
tioning of helix 12, and thus preserved the
high receptor constitutive activity of ERR-γ.
It is evident that the binding ability of
BPA to ERR-γ should be examined by means
of tritium-labeled BPA. Fortunately, [3H]BPA
is now commercially available; thus, in the pre-
sent study we performed the first saturation
binding assay for direct exploration of the
binding characteristics of BPA. We then estab-
lished a competitive receptor binding assay in
which chemicals were assessed for their ability
to displace [3H]BPA from the receptor bind-
ing pocket. In particular, industrial chemical
products of BPA analogs were inspected
structurally in order to better understand the
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BACKGROUND: Various lines of evidence have shown that bisphenol A [BPA; HO-C6H4-C(CH3)2-
C6H4-OH] acts as an endocrine disruptor when present in very low doses. We have recently
demonstrated that BPA binds strongly to human estrogen-related receptor-γ (ERR-γ) in a binding
assay using [3H]4-hydroxytamoxifen ([3H]4-OHT). We also demonstrated that BPA inhibits the
deactivation activity of 4-OHT.
OBJECTIVES: In the present study, we intended to obtain direct evidence that BPA interacts with
ERR-γ as a strong binder, and also to clarify the structural requirements of BPA for its binding to
ERR-γ.
METHODS: We examined [3H]BPA in the saturation binding assay using the ligand binding domain
of ERR-γ and analyzed the result using Scatchard plot analysis. A number of BPA derivatives were
tested in the competitive binding assay using [3H]BPA as a tracer and in the luciferase reporter
gene assay.
RESULTS: [3H]BPA showed a KD of 5.50 nM at a Bmax of 14.4 nmol/mg. When we examined BPA
derivatives to evaluate the structural essentials required for the binding of BPA to ERR-γ, we found
that only one of the two phenol-hydroxyl groups was essential for the full binding. The maximal
activity was attained when one of the methyl groups was removed. All of the potent BPA deriva-
tives retained a high constitutive basal activity of ERR-γ in the luciferase reporter gene assay and
exhibited a distinct inhibitory activity against 4-OHT.
CONCLUSION: These results indicate that the phenol derivatives are potent candidates for the
endocrine disruptor that binds to ERR-γ.
KEY WORDS: bisphenol A, constitutive activity, endocrine disruptor, estrogen receptor, estrogen-
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structural elements of BPA that are required
for binding to the ERR. Here we describe the
structural elements of BPA that are required
for the binding to ERR-γ–LBD and for main-
taining the receptor in an active conformation.
Materials and Methods
Chemicals. We purchased 2,2-bis(4-hydroxy-
phenyl)propane and 4,4-isopropylidene-
diphenol, both denoted as BPA, from Tokyo
Kasei Kogyo Co. (Tokyo, Japan), Nakarai
Tesque (Kyoto, Japan), Aldrich (Madison,
WI, USA), Junsei Chemical (Tokyo, Japan),
Acros (Geel, Belgium), Lancaster Synthesis
(Windham, NH, USA), Merck (Darmstadt,
Germany), and Fluka (Buchs, Switzerland).
The purity designated on the labels varied
from 95 to 99%. We also obtained the follow-
ing analogs of BPA: bisphenol AF [2,2-bis(4-
hydroxyphenyl)hexafluoropropane; Tokyo
Kasei], bisphenol AP [4,4´-(1-phenylethyli-
dene)bisphenol; Tokyo Kasei], bisphenol B
[2,2-bis(4-hydroxyphenyl)butane; Tokyo
Kasei], bisphenol E [2,2-bis(4-hydroxy-
phenyl)ethane; Aldrich], and bisphenol F
[bis(4-hydroxyphenyl)methane; Tokyo Kasei].
4-α-Cumylphenol [2-(4-hydroxyphenyl)-
2-phenylpropane], 4-tert-amylphenol, 4-tert-
butylphenol, 4-isopropylphenol, and
4-ethylphenol were obtained from Tokyo
Kasei. 2,2-Diphenyl propane, and 4-tert-
octylphenol were obtained from Aldrich, and
p-cresol and phenol from Kishida Chemical
(Osaka, Japan).
Preparation of receptor protein GST-fused
ERR-γ–LBD. ERR-γ–LBD was ampliﬁed from
a human kidney cDNA library (Clontech
Laboratories, Mountain View, CA, USA) by
polymerase chain reaction (PCR) using gene-
specific primers and cloned into pGEX6P-1
(Amersham Biosciences, Piscataway, NJ,
USA). Glutathione S-transferase (GST)–fused
receptor protein expressed in Escherichia coli
BL21α was puriﬁed on an afﬁnity column of
glutathione-sepharose 4B (GE Healthcare Bio-
Sciences Co., Piscataway, NJ, USA) to obtain
GST-ERR-γ–LBD. The glutathione used for
elution of GST-ERR-γ–LBD from the column
was removed by gel ﬁltration on a column of
Sephadex G-10 (15 × 100 mm; GE Healthcare
Bio-Sciences Co.) equilibrated with 50 mM
Tris-HCl (pH 8.0), and the protein content
(506.24 µg/mL) was estimated by the Bradford
method using a Protein Assay CBB Solution
(Nakarai Tesque). Preparation of GST-fused
ER-α–LBD was carried out as described previ-
ously (Takayanagi et al. 2006).
Radioligand binding assays for saturation
binding. The saturation binding assay for
GST-ERR-γ–LBD was conducted at 4°C
using [3H]BPA (5 Ci/mmol; Moravek
Biochemicals, Brea, CA, USA) with or with-
out BPA (10 µM in the final solution).
Puriﬁed protein (0.32 µg/mL) was incubated
with increasing concentrations of [3H]BPA
(2.1–24.3 nM) in a ﬁnal volume of 100 µL of
binding buffer [10 mM HEPES (pH 7.5),
50 mM sodium chloride, 2 mM magnesium
chloride, 1 mM EDTA, 2 mM CHAPS {3-
[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate}, and 2 mg/mL γ-globulin].
Nonspecific binding was determined in a
parallel set of incubations that included
10 µM nonradiolabeled BPA. After incuba-
tion for 2 hr at 4°C, all the fractions were ﬁl-
tered by the direct vacuum ﬁltration method
(MultiScreenHTS HV, 0.45 µm pore size;
Millipore, Billerica, MA, USA) for the B/F
separation (the separation of receptor-bound
ligand from free ligand) (Nakai et al. 1999).
Filtration was carried out on a multiscreen
separation system (Millipore). Before filtra-
tion, 100 µL of 1% dextran-coated charcoal
(DCC) (Sigma) in phosphate buffer (pH 7.4)
was added to the assay vessels, and the mix-
ture was incubated for 10 min on ice. The
radioactivity of the filtered solution was
counted on a liquid scintillation counter
(LS6500; Beckman Coulter, Fullerton, CA,
USA). The saturation assay was performed in
triplicate. The specific binding of [3H]BPA
was calculated by subtracting the nonspeciﬁc
binding from the total binding.
Radioligand binding assays for competi-
tive binding. BPA and the BPA-related
chemicals were dissolved in a binding buffer
containing 0.3–1.0% N,N-dimethylsulfoxide
(DMSO). These compounds were examined
for their ability to inhibit the binding of
[3H]BPA (3 nM in the final solution) to
GST-ERR-γ–LBD (0.32 µg/mL in the final
solution). The reaction mixtures were incu-
bated for 2 hr at 4°C and free radioligand
was removed with 1% DCC by filtration as
described above. Radioactivity was deter-
mined on a liquid scintillation counter
(TopCount NXT; PerkinElmer Life Sciences
Tokyo, Japan). The IC50 values (the concen-
trations for the half-maximal inhibition) were
calculated from the dose–response curves
obtained using the nonlinear analysis pro-
gram ALLFIT (De Lean et al. 1978). Each
assay was performed in duplicate and
repeated at least three times. The competitive
binding assay for GST-ER-α–LBD was car-
ried out as described above using [3H]E2
(5.74 TBq/mmol; Amersham Biosciences,
Buckinghamshire, UK).
Cell culture and transient transfection
assays. HeLa cells were maintained in Eagle’s
MEM (EMEM; Nissui, Tokyo, Japan) in the
presence of 10% (vol/vol) fetal bovine serum
at 37°C. For luciferase assays, HeLa cells were
seeded at 5 × 105 cells/6-cm dish for 24 hr
and then transfected with 4 µg of reporter
gene (pGL3/3×ERRE) and 3 µg of ERR-γ
expression plasmids (pcDNA3/ERR-γ) by
Lipofectamine Plus reagent (Invitrogen Japan,
Tokyo, Japan) according to the manufacturer’s
protocol. Approximately 24 hr after transfec-
tion, cells were harvested and plated into
96-well plates at 5 × 104 cells/well. The cells
were then treated with varying doses of chemi-
cals diluted with 1% bovine serum albumin/
phosphate-buffered saline (BSA/PBS, vol/vol).
To measure the antagonistic activity, a fixed
concentration of compounds (10–5 M to
10–10 M in the ﬁnal solution) was added along
with 4-OHT. After 24 hr, luciferase activity
was measured with the appropriate reagent
using a Luciferase Assay System (Promega,
Madison, WI, USA) according to the manu-
facturer’s instructions. Light emission was
measured using a Wallac 1420 ARVOsx multi-
label counter (PerkinElmer). Cells treated with
1% BSA/PBS were used as a vehicle control.
Each assay was performed in triplicate and
repeated at least three times.
Results and Discussion
Highly speciﬁc binding of BPA to ERR-γ. To
demonstrate the direct binding of BPA to
ERR-γ, we ﬁrst attempted to establish a satu-
ration receptor binding assay using radio-
labeled BPA. We analyzed the saturation
binding of [3H]BPA against the recombinant
ERR-γ–LBD protein, to which GST was
fused at the N-terminus. In the actual receptor
binding assay, we used [3H]BPA (2.0–24 nM)
against puriﬁed protein at a concentration of
0.32 µg/mL, which corresponds to a concen-
tration of 6.3 nM. The removal of receptor-
free [3H]BPA was carried out with 1% DCC.
In this procedure, DCC mixtures were trans-
ferred to a 96-well HV-plate with a filter
(0.45-µm pore size) for direct vacuum.
As shown in Figure 1A, the binding of
BPA to ERR-γ was specific and saturated.
Specific binding of [3H]BPA to ERR-γ was
estimated to be approximately 80%, which
we judged to be a very high value. In other
words, the level of nonspecific binding of
[3H]BPA was very low (Figure 1A). The high
level of specific binding of [3H]BPA clearly
demonstrated that BPA has no structural ele-
ments for nonspeciﬁc binding to the receptor
protein and exclusively occupies the binding
pocket of ERR-γ–LBD. GST did not bind
[3H]BPA at all. It should be noted that the
specific binding of [3H]4-OHT was only
about 50% (Takayanagi et al. 2006).
The Scatchard plot analysis showed a dis-
tinct single binding mode (Figure 1B). From
the slope, the binding afﬁnity constant (KD)
was calculated to be 5.50 nM. The receptor
density (Bmax) was estimated to be 14.4
nmol/mg protein, which is roughly compati-
ble with the calculated value of 18.9 nmol/mg
protein. The Bmax value of [3H]4-OHT is
much smaller than that of [3H]BPA. These
results further demonstrate that ERR-γ binds
[3H]BPA very speciﬁcally and exclusively.Binding ability of BPA to ERR-γ. We
performed the competitive receptor binding
assay using [3H]BPA (3 nM in the ﬁnal solu-
tion) for GST–ERR-γ–LBD (0.32 µg/mL in
the ﬁnal solution). To conﬁrm that BPA is a
truly specific ligand for ERR-γ, we tested all
nonradiolabeled BPA compounds available in
Japan, which we obtained from seven differ-
ent reagent companies. Because the com-
pounds all had different levels of purity
(95–99%), we adjusted their initial concen-
tration, 1.0 × 10–2 M, based on the purity
indicated on the label.
We found that BPA displaces [3H]BPA in
a dose-dependent manner. Its binding curve
was sigmoidal in a single binding mode
(slope = ~ 1), which afforded an average IC50
value of 9.78 nM. We found all BPA com-
pounds purchased to be equally potent. These
results clearly demonstrate that BPA binds
very strongly to the NR ERR-γ.
4-OHT as a potent displacer of BPA in
ERR-γ. 4-OHT has been reported to potently
displace [3H]4-OHT in the binding to ERR-γ
(Greschik et al. 2004; Takayanagi et al. 2006).
In the present study, 4-OHT very potently dis-
placed [3H]BPA (IC50 = 10.9 nM) (Table 1).
BPA and 4-OHT yielded sigmoidal binding
curves indistinguishable from each other (data
not shown), indicating that the two are
almost equipotent. These results obtained
using the [3H]BPA tracer were almost iden-
tical to those obtained by [3H]4-OHT
(Takayanagi et al. 2006).
BPA and 4-OHT share only a phenol
group, and thus the phenol groups of these
compounds are highly likely to occupy the
same binding site in the ERR-γ receptor.
Because the phenol group of 4-OHT is
anchored by hydrogen bonds to Glu275 and
Arg316 of ERR-γ (Greschik et al. 2004), the
phenol group of BPA may also bind to these
ERR-γ residues. Indeed, this has been proven
by our recent X-ray crystal structure analysis
of the complex between BPA and human
ERR-γ–LBD (Matsushima et al. 2007).
Hereafter, we designate the benzene ring of
this phenol group of BPA as the A-ring and
the additional benzene ring as the B-ring.
BPA-methyl as a structural requirement
for binding to ERR-γ. We evaluated the role
of the two methyl (CH3) groups on the sp3-C
atom of BPA in binding to ERR-γ by a series
of analogs of BPA, HO-C6H4-C(CH3)2-
C6H4-OH. First, we examined the effect of
incorporation of the methyl group on the
binding affinity of BPA. When CH3 was
Okada et al.
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Figure 2. Chemical structure of BPA and its derivatives and their dose–response curves in the radioligand
receptor binding assay for ERR-γ. (A) Chemical structures of BPA (two methyl groups) and its derivatives:
bisphenol B (a methyl group and an ethyl group) and bisphenol AP (a methyl group and a phenyl group).
(B) Binding activities of BPA, bisphenol B, and bisphenol AP examined by the competitive binding assay
using [3H]BPA and GST–ERR-γ–LBD. (C) Chemical structures of bisphenol E (one methyl group) and its
derivatives, bisphenol F and bisphenol AF [two triﬂuoromethyl groups (CF3)]. (D) Binding activities of BPA,
bisphenol E, bisphenol F, and bisphenol AP examined by the competitive binding assay. (B) and (D) each
show representative curves with the IC50 values closest to the mean IC50 from at least five independent
assays for each compound. B/B0 is the relative inhibitory activity estimated from the calculation of the per-
centage of displacement by the chemical tested (B) against the speciﬁc binding (B0 = 100%) of [3H]BPA.
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Table 1. Receptor binding affinity (mean ± SE) of
BPA and its analogs, and 4-OHT for ERR-γ.
Chemical Binding afﬁnity (IC50, nM)
BPA 9.78 ± 0.87
Bisphenol AF 358 ± 30.5
Bisphenol AP 123 ± 15.1
Bisphenol B 26.3 ± 2.65
Bisphenol E 8.14 ± 0.83
Bisphenol F 131 ± 17.9
4-OHT 10.9 ± 0.91
Figure 1. The saturation binding analysis of BPA for
ERR-γ. (A) Saturation binding curve of [3H]BPA for
the recombinant human ERR-γ–LBD showing total,
nonspeciﬁc, and speciﬁc binding. Determination of
nonspecific binding was carried out by excess
unlabeled BPA (10 µM). (B) Binding data analyzed
by Scatchard plot analysis to estimate the dissoci-
ation constant (KD) and the receptor density (Bmax).
The plot was linear, the KD value was estimated to
be 5.50 ± 0.87 nM, and Bmax was 14.4 nmol/mg pro-
tein. The saturation binding analysis was per-
formed in duplicate and repeated four times.
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Specificincorporated into the parent methyl group to
produce HO-C6H4-C(CH3)(CH2CH3)-
C6H4-OH (Figure 2A), we found the result-
ing bisphenol B to be approximately half as
potent (IC50 = 26.3 nM) as BPA (Table 1).
This result clearly indicates that a bulky
group on the central sp3-C atom is obviously
disadvantageous in terms of the binding of
BPA to ERR-γ’s binding pocket.
On the other hand, an enhancement of
activity was observed when one of the methyl
groups was eliminated from BPA. The result-
ing bisphenol E [HO-C6H4-CH(CH3)-
C6H4-OH] (Figure 2C) exhibited slightly
better binding activity (IC50 = 8.14 nM) than
BPA (Table 1). Bisphenol E is indeed the
most potent chemical to date for the NR
ERR-γ (Figure 2D). The maximal activity was
attained when one of the methyl groups was
removed from BPA. Apparently, the concomi-
tance of two methyl groups on the central
sp3-C atom of BPA is disadvantageous and
unfavorable.
The fact that a single methyl group had the
best ﬁt for ERR-γ was further demonstrated by
the diminished activity of bisphenol AP, which
has a phenyl group in place of the hydrogen
atom that is found in bisphenol E (Figure 2A).
Bisphenol AP exhibited approximately 15-fold
weaker binding afﬁnity for ERR-γ than bisphe-
nol E, with IC50 = 123 nM (Figure 2B,
Table 1). Steric hindrance by the benzene ring,
as well as its electron-rich characteristics, might
be responsible for this drop in the receptor
binding afﬁnity of bisphenol AP.
The importance of the remaining methyl
group in bisphenol E became evident from
the drastically reduced activity of bisphenol F
[HO-C6H4-CH2-C6H4-OH]. This com-
pound was approximately 16-fold less potent
than bisphenol E, exhibiting an IC50 value of
131 nM (Table 1). All of these results clearly
indicate that one of the two methyl groups is
involved in the intermolecular interaction
with the receptor residue(s). The interaction
involving the CH3 group is a kind of
hydrophobic interaction, such as CH3-alkyl
and CH/π interactions.
The fundamental nature of this inter-
action involving the CH3 group became
rather apparent from the binding result of
bisphenol AF [HO-C6H4-C(CF3)2-C6H4-
OH]. The CH3→CF3 substitution in BPA
creates this compound (Figure 2C), which has
two electron-rich triﬂuoromethyl CF3 groups
instead of the rather electron-poor methyl
CH3 group. The molecular size of CF3 is
almost equal to that of CH3. A drastically
reduced activity of bisphenol AF, about
35-fold less potent (358 nM) than BPA
(Table 1), thus demonstrates that the BPA’s
CH3 group is in an electrostatic interaction
with the electron-rich residue(s) of the recep-
tor. Replacement of CH3 with CF3 is defi-
nitely disadvantageous, because CF3 is very
electron-rich and thus brings about a strong
repulsion with such electron-rich residues of
the receptor. One of the electron-rich candi-
dates of the receptor is the aromatic ring of
Phe, Tyr, His, and Trp. Based on the reported
X-ray crystal structure of ERR-γ, feasible can-
didates are Phe-435 and Phe-450 (Greschik
et al. 2002, 2004; Matsushima et al. 2007;
Wang et al. 2006).
A single phenol-hydroxyl group is enough
for BPA to bind to ERR-γ. BPA has a very sim-
ple symmetrical chemical structure of HO-
C6H4-C(CH3)2-C6H4-OH (Figure 2A).
When one of the phenol-hydroxyl groups
(–OH) of BPA was eliminated, the resulting
4-α-cumylphenol (HO-C6H4-C(CH3)2-
C6H5; Figure 3A) still bound very strongly to
ERR-γ. 4-α-Cumylphenol was as potent as
BPA (Figure 3B), having an IC50 value of
10.6 nM (Table 2). Contrary to the expecta-
tion that both of the phenol-hydroxyl groups
of BPA would participate in the hydrogen
bonds, this result indicates that the second
hydroxyl group does not necessarily participate
in the hydrogen bonding. Given that this
hydroxyl group forms a hydrogen bond with
the ERR-γ receptor residue, the bond would be
considered extremely weak, as suggested by the
X-ray crystal analysis of 4-α-cumylphenol–
ERR-γ complex (Matsushima A, Teramoto T,
Okada H, Liu X, Tokunaga T, Kakuta Y,
Shimohigashi Y, unpublished data).
When both of the phenol-hydroxyl groups
were eliminated from BPA, the resulting
2,2-diphenyl propane [C6H5-C(CH3)2-C6H5]
was almost completely inactive (Figure 3B,
Table 2). This compound elicits only about
30% inhibition of the binding of [3H]BPA at
the 1-µM concentration, whereas BPA almost
completely inhibits the binding of [3H]BPA at
this concentration (Figure 3B). It is clear that
one of the phenol-hydroxyl groups of BPA is
indispensable for the interaction with a bind-
ing pocket of ERR-γ. These results, together
with the fact that 4-α-cumylphenol and BPA
are equipotent, emphasizes the signiﬁcance of
one of the two phenol groups in the inter-
action of BPA with ERR-γ. As described
above, this hydroxyl group should be attached
to the benzene A-ring. It became apparent that
the phenol-hydroxyl group attached to another
phenol-benzene ring (B-ring) is not necessarily
required for binding of BPA to ERR-γ.
BPA-phenol as a structural requirement
for binding to ERR-γ. As described above,
4-α-cumylphenol is as active as BPA. The
importance of the benzene B-ring can be
examined by replacing the B-ring with the
alkyl groups. When the benzene B-ring of
4-α-cumylphenol was substituted with either
methyl or ethyl, the resulting 4-tert-butyl-
phenol [HO-C6H4-C(CH3)2-CH3] and
Direct evidence of bisphenol A binding to human ERR-γ
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Figure 3. Chemical structure of BPA and its derivatives lacking the hydroxyl group(s) and their dose–
response curves in the radioligand receptor binding assay for ERR-γ. (A) Chemical structure of BPA and its
derivatives lacking the hydroxyl group(s): 4-α-cumylphenol (without one hydroxyl group from BPA), and
2,2-diphenylpropane (without either hydroxyl groups from BPA). (B) Binding activities of BPA,
4-α-cumylphenol, and 2,2-diphenylpropane examined by the competitive binding assay using [3H]BPA and
GST-ERR-γ–LBD; representative curves indicate the IC50 value closest to the mean IC50 from at least ﬁve
independent assays for each compound.
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Table 2. The receptor binding afﬁnity (mean ± SE) of
BPA and its derivatives lacking of the phenol group
for human ERR-γ.
Chemical Binding afﬁnity (IC50, nM)
BPA 9.78 ± 0.87
4-α-Cumylphenol 10.6 ± 0.87
2,2-Diphenylpropane ND
4-tert-Butylphenol 26.1 ± 2.45
4-tert-Amylphenol 33.2 ± 2.85
4-Isopropylphenol 71.1 ± 7.73
4-tert-Octylphenol 238 ± 28.1
4-Ethylphenol 289 ± 45.9
p-Cresol 1,290 ± 72.5
Phenol ND
ND, not determined (IC50 value could not be calculated
because of extremely weak binding activity, even at a
10 µM concentration).Okada et al.
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4-tert-amylphenol [HO-C6H4-C(CH3)2-
CH2CH3] (Figure 4A) were considerably
potent (Figure 4B), with values of 26.1 nM
and 33.2 nM, respectively (Table 2). This
reveals that alkyl groups can be substituted for
the aromatic benzene ring without affecting
the basal binding capability.
However, because both 4-tert-butylphenol
and 4-tert-amylphenol are still a few times less
active than 4-α-cumylphenol, a speciﬁc binding
site of ERR-γ appears to prefer the aromatic
benzene ring to the alkyl groups. This suggests
that BPA’s second phenol-phenyl group
(benzene B-ring) is in the π interaction with
the receptor residue(s), that is, either a XH/π
interaction (X = N, O, and C) or a π/π interac-
tion. The most plausible candidate for the
receptor residue in this interaction is the Tyr
residue at position 326 of ERR-γ. Indeed, the
phenol-hydroxyl group of this Tyr-326 was
found in the OH/π interaction with the B-ring
of BPA (Matsushima et al. 2007).
In a BPA molecule, two C6H4-OH (phe-
nol) groups are connected to the sp3 carbon
atom (sp3-C) together with two CH3
(methyl) groups. The most simple structure–
activity study is to compare the activity of
compounds lacking one of these groups. The
compound that lacks the phenol group is
4-isopropylphenol [HO-C6H4-CH(CH3)2]
(Figure 5A), and this para-isopropyl phenol
was fairly potent at displacing [3H]BPA
(Figure 5B), with an IC50 value of 71.1 nM
(Table 2). However, 4-isopropylphenol was
still approximately 7-fold less active than
BPA, indicating that the phenol backbone
structure is an essential structural element for
the binding to ERR-γ.
When one of the two methyl groups was
eliminated from 4-isopropylphenol, the result-
ing 4-ethylphenol [HO-C6H4-CH2-CH3]
(Figure 5A) was found to be very weakly active
(289 nM) (Table 2). Elimination of another
methyl group still afforded a compound of
inactive p-cresol [HO-C6H4-CH3], but with
the IC50 value being approximately 1.3 µM.
Phenol [HO-C6H5] tended to bind to ERR-γ
(Figure 5B). These results clearly indicate that
the phenol group is a core structure for the
attachment of BPA to ERR-γ.
4-Alkyl phenols as putative potent binders
to ERR-γ. Attachment of the methyl group to
4-isopropylphenol [HO-C6H4-CH(CH3)2]
to create 4-tert-butylphenol [HO-C6H4-
C(CH3)3] considerably facilitates the binding
of the phenol derivative to ERR-γ (Table 2).
4-tert-Amylphenol [HO-C6H4-C(CH3)2-
CH2CH3] is almost as active as 4-tert-
butylphenol. However, 4-tert-octylphenol
[HO-C6H4-C(CH3)2-CH2-C(CH3)3]
(Figure 4B) was signiﬁcantly weaker (approxi-
mately 10 times less potent) than 4-tert-
butylphenol (Table 2). Thus, the activities of
HO-C6H 4-C(CH3) 2-CH(CH3) 2, 
HO-C6H4-C(CH3)2-CH(CH3)3, HO-C6H4-
C(CH3)2-CH2-CH2-CH3, and HO-C6H4-
C(CH3)2-CH2-CH(CH3)2 are expected to be
intermediate between those of 4-tert-amyl-
phenol and 4-tert-octylphenol, although these
molecules are not commercially available. It
appears that, among the 4-alkylphenols of
HO-C6H4-C(CH3)2-CnH2n+1 (=R), 4-tert-
butylphenol (R = CH3) and 4-tert-amylphenol
(R = CH2-CH3) show the maximum competi-
tive activity with the binding of ERR-γ.
The structural comparison of HO-C6H4-
C(CH3)2-CH3 (4-tert-butylphenol), HO-
C6H4-C(CH3)2-CH2CH3 (4-tert-amylphenol),
Figure 5. Chemical structure of BPA and a series of alkyl phenols and their dose–response curves in the
radioligand receptor binding assay for ERR-γ. (A) Chemical structure of BPA and its derivatives with the
alkyl group at the para position: 4-isopropylphenol (a 4-isopropyl group); 4-ethylphenol (an ethyl group);
p-cresol (a methyl group); and phenol (a hydrogen atom). (B) Binding activities of BPA, 4-isopropylphenol,
4-ethylphenol, p-cresol, and phenol examined by the competitive binding assay using [3H]BPA and
GST-ERR-γ–LBD; representative curves indicate the IC50 value closest to the mean IC50 from at least ﬁve
independent assays for each compound.
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Figure 4. Chemical structure of BPA and its derivatives lacking the phenol group and their dose–response
curves in the radioligand receptor binding assay for ERR-γ. (A) Chemical structure of BPA and its deriva-
tives with the alkyl group at the position of phenol group: 4-tert-butylphenol (a methyl group); 4-tert-
amylphenol (an ethyl group); and 4-tert-octylphenol (a tert-butyl methyl group). (B) Binding activities of
BPA, 4-tert-butylphenol, 4-tert-amylphenol, and 4-tert-octylphenol examined by the competitive binding
assay using [3H]BPA and GST-ERR-γ–LBD; representative curves indicate the IC50 value closest to the
mean IC50 from at least ﬁve independent assays for each compound.
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CH3 CH2 CCand BPA HO-C6H4-C(CH3)2-C6H4-OH
clearly indicated that the R group should not be
bulky for high receptor binding activity. A plain
π electron-rich benzene aromatic ring is thus
optimal for interaction with the receptor
residue of ERR-γ-Tyr326.
Inhibitory activity of BPA derivatives for
ERR-γ. We found that BPA retained a high
constitutive basal activity of ERR-γ in the
luciferase reporter gene assay (Figure 6A).
ERR-γ is in a full activation with no ligand; it
is one of the self-activated NRs and is deacti-
vated by the so-called “inverse agonists” such
as 4-OHT (Greschik et al. 2004; Takayanagi
et al. 2006). Although BPA shows no appar-
ent effect on the high basal activity of ERR-γ,
BPA evidently antagonizes or inhibits the
deactivation activity of 4-OHT in a dose-
dependent manner (Figure 6B), as reported by
Takayanagi et al. (2006). This neutral antago-
nist is a distinct inhibitor or suppressor of the
inverse agonist, reversing the deactivation con-
formation to the activation conformation.
All of the potent BPA derivatives (i.e.,
bisphenol E, bisphenol AF, 4-α-cumylphenol,
and 4-tert-butylphenol) were found, just like
BPA, to retain a high constitutive basal activ-
ity of ERR-γ in the same luciferase reporter
gene assay (Figure 6C). In addition, these
compounds inhibited the inverse agonist activ-
ity of 4-OHT and thus were speciﬁc inhibitors
against the inverse agonist 4-OHT. Their abil-
ities to antagonize 4-OHT are approximately
one order lower than their binding potencies
to ERR-γ (Figure 6B,D). This discrepancy is
probably caused by the inclusion of a number
of co-effecter proteins for eliciting a gene
expression in the luciferase reporter gene assay.
Receptor selectivity of BPA derivatives for
ERR-γ over ER-α. We classiﬁed BPA and its
derivatives into the four groups, depending
on their receptor binding afﬁnity for ERR-γ:
that is, group A, BPA and chemicals as potent
as BPA; group B, chemicals considerably
potent; group C, chemicals moderately
potent; and group D, inactive chemicals. All
chemicals were then examined for their ability
to bind to ER-α, and the affinity measured
was compared respectively with that for
ERR-γ (Table 3). As reported previously
(Takayanagi et al. 2006), BPA is highly selec-
tive for ERR-γ. It binds to ER-α only weakly;
we calculated BPA’s receptor selectivity to be
105, which suggests that BPA prefers ERR-γ
105 times more strongly than ER-α. Other
group A compounds, namely, bisphenol E
and 4-α-cumylphenol, were also greatly selec-
tive for ERR-γ (Table 3). In particular,
bisphenol E was found to be exclusively selec-
tive and specific for ERR-γ because it was
almost completely inactive for ER-α.
para-Alkyl phenols in group B (IC50
ERR-γ
= of 26–71 nM) were also almost completely
inactive for ER-α (Table 3). Those include
Direct evidence of bisphenol A binding to human ERR-γ
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Figure 6. Luciferase-reporter gene assay of BPA and its derivatives for human ERR-γ. (A) Deactivation of
the fully activated human ERR-γ by the inverse agonist 4-OHT and sustainment by BPA. (B) Reversing
activity of BPA, bisphenol E, and bisphenol AF against the inverse agonist activity of 1.0 µM 4-OHT; 1.0 µM
4-OHT exhibited approximately 0.4-fold deactivation, and the inhibitory activities are shown by the percent-
age of relative activity. (C) Sustainment of the fully activated human ERR-γ by bisphenol E and bisphenol AF
together with inverse agonist activity by 4-OHT. (D) Reversing activity of BPA, 4-α-cumylphenol, and
4-tert-butylphenol; the inverse agonist activity of 4-OHT was clearly reversed by all bisphenols tested in a
dose-dependent manner. Data are from a single experiment performed in triplicate; two additional experi-
ments gave similar results. High basal constitutive activity of ERR-γ was evaluated with the luciferase-
reporter plasmid (pGL3/3 × ERRE), and the highest activity was estimated in a cell preparation of 1.0 × 105
HeLa cells/well.
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Table 3. Receptor binding afﬁnity (mean ± SE; n = 3) of BPA and its analogs for ER-α and their receptor
selectivity for ERR-γ over ER-α.
Binding afﬁnity for ERR-γ receptor selectivity
Chemical ER-α (IC50, nM) ER-α (IC50, nM)/ERR-γ (IC50, nM)
E2 0.88 ± 0.13 Exclusively ER-α
Group A (chemicals as active as BPA for ERR-γ)
Bisphenol E ND Exclusively ERR-γ
BPA 1,030 ± 146 105
4-α-Cumylphenol 4,770 ± 510 450
Group B (chemicals considerably potent for ERR-γ)
Bisphenol B 246 ±29.7 9.46
4-tert-Butylphenol ND Exclusively ERR-γ
4-tert-Amylphenol ND Exclusively ERR-γ
4-Isopropylphenol ND Exclusively ERR-γ
Group C (chemicals moderately potent for ERR-γ)
Bisphenol AP 361 ± 22.6 2.93
Bisphenol F ND Exclusively ERR-γ
4-tert-Octylphenol 925 ± 83.9 3.89
4-Ethylphenol ND Exclusively ERR-γ
Bisphenol AF 53.4 ± 7.28 0.15
Group D (chemicals extremely weak or inactive for ERR-γ)
2,2-Diphenylpropane ND Inactive for both receptors
p-Cresol ND Almost inactive for both receptors
Phenol ND Inactive for both receptors
ND, not determined (IC50 value could not be calculated because of extremely weak binding activity even at a 10-µM
concentration).4-tert-butylphenol, 4-tert-amylphenol, and
4-isopropylphenol, and they were fully selec-
tive and specific for ERR-γ. In contrast,
bisphenol B was very weakly active (246 nM)
for ER-α, although it was still selective (about
9.5 times) for ERR-γ.
Among group C chemicals (IC50
ERR-γ =
120–350 nM), bisphenol F was almost com-
pletely inactive for ER-α, making it fully selec-
tive for ERR-γ (Table 3). This was also true
for 4-ethylphenol. Bisphenol AP showed a
weak binding afﬁnity (361 nM) for ER-α, but
it was still selective (about 3 times) for ERR-γ.
However, bisphenol AF emerged as a ligand
selective for ER-α with a selectivity ratio of
0.15 (Table 3). The reciprocal of 0.15 [i.e.,
ERR-γ (IC50)/ER-α (IC50) = 6.67] denotes a
selectivity ratio of bisphenol AF for ER-α.
The results clearly indicate that the alkyl
groups on the central sp3-C atom of bisphenol
derivatives play a key role in selection of the
NR ERR-γ and ER-α. When we checked the
receptor binding activities of one series of
bisphenol derivatives (i.e., bisphenol E, BPA,
bisphenol B, bisphenol AP, and bisphenol AF),
we found this line-up to be the order of com-
pounds with increasing affinity to ER-α. At
the same time, it was the order of compounds
with decreasing affinity to ERR-γ. ERR-γ
prefers the less bulky and less electrophilic alkyl
groups, whereas ER-α appears to prefer the
bulkier and more electrophilic alkyl groups.
4-tert-Octylphenol is a well-known
endocrine disruptor candidate, but it was only
moderately potent for ERR-γ (IC50 = 238 nM;
Table 2). However, it was considerably weak
for ER-α, with an IC50 of 925 nM; thus, we
judged 4-tert-octylphenol to be somewhat
selective (approximately 4 times) for ERR-γ.
Another representative endocrine disruptor
candidate is 4-nonylphenol, which was mod-
erately active for ERR-γ (Takayanagi et al.
2006). Thus, 4-nonylphenol was slightly more
selective for ERR-γ. However, some 4-alkyl
phenols are distinctly more potent for ERR-γ
than 4-tert-octylphenol and 4-nonylphenol:
4-tert-butylphenol, 4-tert-amylphenol, and
4-isopropylphenol. These 4-alkyl phenols are
definitely novel candidates of the endocrine
disruptor speciﬁc for ERR-γ.
Conclusion
In the present study we have shown that all the
structural elements of BPA—the phenol and
methyl groups and the phenyl group on the
central sp3-C atom—are prerequisite for bind-
ing to the NR ERR-γ. Furthermore, we have
shown that the phenol derivatives are potent
candidates for the endocrine disruptor that
binds to ERR-γ. The binding affinity of
[3H]BPA to ERR-γ–LBD is extremely high,
with a KD value of 5.50 nM. Thus, it appears
to be important to evaluate whether the previ-
ously reported effects of BPA at low doses are
mediated through ERR-γ and its specific
target gene(s).
At the same time, it is necessary to clarify
the physiologic roles of ERR-γ and to examine
the degree and ways in which BPA may inﬂu-
ence these. This is particularly important
because ERR-γ is expressed in a tissue-
restricted manner—for example, it is expressed
very strongly in the mammalian fetal brain
and placenta—at sites that could have impor-
tant outcomes for newborns. Recently, many
lines of evidence have indicated that low doses
of BPA affects the central nervous system
(reviewed by vom Saal and Welshons 2005;
Welshons et al. 2003, 2006). The molecular
mechanism for these effects could involve, at
least in part, the high afﬁnity binding of BPA
to ERR-γ. A similar phenomenon may be
observed for other NRs, and the exploration
of such chemical–receptor interactions
requires a specific assay system or concept
applicable to all the NRs.
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